Extracardiac Tracer Uptake on Technetium-99m–Labeled Pyrophosphate Scintigraphy in Patients With Non-transthyretin Cardiac Amyloidosis
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: In patients with wild-type transthyretin (ATTRwt) amyloidosis, formerly known as senile systemic amyloidosis, ATTRwt deposition in soft tissues causes orthopedic diseases several years before cardiac manifestations. However, few studies have demonstrated extracardiac ATTRwt deposition before myocardial deposition through imaging modalities. This retrospective study aimed to determine whether technetium-99m–labeled pyrophosphate (99mTc-PYP) is taken up by extracardiac tissue, particularly skeletal muscle, in patients with non-ATTR cardiac amyloidosis (CA), defined as no myocardial tracer uptake. Patients and Methods: Chest-centered and abdomen-centered 99mTc-PYP scintigraphy images were obtained 2 hours after the intravenous injection of the tracer (20 mCi). First, the frequency of 99mTc-PYP uptake in the internal oblique muscle (IOM)—where an association between tracer uptake and histologic ATTRwt deposition has been reported in patients with ATTRwt-CA—was investigated in patients with non–ATTR-CA. Second, the study participants were divided into 2 subgroups according to the presence (positive group) or absence (negative group) of 99mTc-PYP uptake in the muscle, and the differences in clinical characteristics were evaluated between the two subgroups. Results: Overall, 125 patients (median age, 85 y; interquartile range, 77–89 y; 51.2% male individuals) were included. The frequency and multivariate predictors of 99mTc-PYP uptake in the IOM were 35.2% and older age (odds ratio, 2.27; 95% CI, 1.04–4.92; P = 0.039), respectively. Conclusions: In patients with non–ATTR-CA, the greatest predictor of 99mTc-PYP uptake in the IOM, suspected to show ATTR deposition, was advanced age. Follow-up of these patients may lead to early detection of ATTR-CA.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Extracardiac Tracer Uptake on Technetium-99m–Labeled Pyrophosphate Scintigraphy in Patients With Non-transthyretin Cardiac Amyloidosis
- Date Crossref
- 14/05/2025
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.